| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Varinder Gupta CEO | XNSE Exchange | Y8971W118 CUSIP |
| IN Country | 2,891 Employees | 17 Feb 2026 Last Dividend | 11 Mar 2025 Last Split | - IPO Date |
IOL Chemicals and Pharmaceuticals Limited is a significant player in the pharmaceutical and chemical manufacturing industry, with a presence in both the Indian and international markets. The company specializes in the production of active pharmaceutical ingredients (APIs) and specialty industrial chemicals, catering to a broad range of healthcare and industrial applications. Incorporated in 1986, IOL Chemicals and Pharmaceuticals Limited has established a strong footprint in Ludhiana, India, leveraging its expertise to deliver high-quality products across multiple sectors.
Active Pharmaceutical Ingredients (APIs): The company manufactures a variety of APIs, including ibuprofen lysinate, ibuprofen sodium, metformin, fenofibrate, lamotrigine, clopidogrel bisulphate, pantoprazole, gabapentin, levetiracetam, and paracetamol. These ingredients are essential for the development of medications aimed at treating a broad range of conditions such as anti-inflammatory, analgesic, antipyretic, anti-diabetic, anti-platelet, anti-cholesterol, anti-convulsant, and anti-cholelithic disorders, as well as for proton pump inhibitor treatments.
Specialty Industrial Chemicals: Alongside its pharmaceutical offerings, IOL Chemicals and Pharmaceuticals produces specialty chemicals like ethyl acetate, iso butyl benzene, acetyl chloride, para amino phenol, and mono chloro acetic acid. These chemicals serve diverse industries, including food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and chemical intermediates, highlighting the company's versatility and broad market reach.